“The market seems to have entered a broad consolidation phase, and there is selective buying happening in the pharma space. Sun Pharma from the attractive pharma space. Traders can buy for a target of over 1700 levels in the next few weeks,” Ruchit Jain, Lead Research, 5paisa.com, said.
